These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30429499)

  • 1. Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects.
    Sundin J; Stridsberg M; Tap J; Derrien M; Le Nevé B; Doré J; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2018 Nov; 8(1):16821. PubMed ID: 30429499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?
    Ohman L; Stridsberg M; Isaksson S; Jerlstad P; Simrén M
    Am J Gastroenterol; 2012 Mar; 107(3):440-7. PubMed ID: 22233694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms.
    Shulman RJ; Öhman L; Stridsberg M; Cain K; Simrén M; Heitkemper M
    Neurogastroenterol Motil; 2019 Jan; 31(1):e13486. PubMed ID: 30298961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation.
    Bennet SMP; Sundin J; Magnusson MK; Strid H; Tap J; Derrien M; Le Nevé B; Doré J; Törnblom H; Simrén M; Öhman L
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13468. PubMed ID: 30230134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity.
    Strid H; Simrén M; Lasson A; Isaksson S; Stridsberg M; Öhman L
    J Crohns Colitis; 2013 Dec; 7(12):e615-22. PubMed ID: 23694857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?
    Camilleri M
    Am J Gastroenterol; 2012 Mar; 107(3):448-50. PubMed ID: 22388024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
    Sundin J; Aziz I; Nordlander S; Polster A; Hu YOO; Hugerth LW; Pennhag AAL; Engstrand L; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2020 Jan; 10(1):593. PubMed ID: 31953505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.
    Carroll IM; Ringel-Kulka T; Keku TO; Chang YH; Packey CD; Sartor RB; Ringel Y
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G799-807. PubMed ID: 21737778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
    Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
    Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.
    Codling C; O'Mahony L; Shanahan F; Quigley EM; Marchesi JR
    Dig Dis Sci; 2010 Feb; 55(2):392-7. PubMed ID: 19693670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.
    Ng SC; Lam EF; Lam TT; Chan Y; Law W; Tse PC; Kamm MA; Sung JJ; Chan FK; Wu JC
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1624-31. PubMed ID: 23800182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
    Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A
    Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
    Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
    Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
    Hou Y; Dong L; Lu X; Shi H; Xu B; Zhong W; Ma L; Wang S; Yang C; He X; Zhao Y; Wang S
    Dig Dis Sci; 2022 Dec; 67(12):5580-5592. PubMed ID: 35879512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.